EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach

Amir Taherkhani iD, Parita Khodadadi iD, Lida Samie iD, Zahra Azadian iD, Zeynab Bayat iD

International Journal of Analytical Chemistry · 14.04.2023 · 2023 · 1-16

DOI: 10.1155/2023/8899240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Analytical Chemistry, erschienen am 14.04.2023. Verfasst von Amir Taherkhani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamadan University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs has led to therapeutic effects in cancer.

Objectives

The present study performed molecular docking and dynamics simulation to identify potential MAPK3 inhibitors from natural flavonoids, possibly leading to drug development in cancer therapy.

Methods

A computational drug discovery approach was performed using the AutoDock tool to identify potential MAPK3 inhibitors from 46 plant-based flavonoids. A cross-validation study was executed using the Schrödinger Maestro docking tool. Molecular dynamics (MD) was executed to evaluate the stability of docked poses between the top-ranked compounds and the MAPK3 catalytic domain. Interactions among the most potent MAPK3 inhibitors and residues within the receptor’s active site were studied using the BIOVIA Discovery Studio Visualizer before and after 100 ns MD simulations.

Results

Kaempferol 3-rutinoside-4′-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 exhibited a magnificent binding affinity to the receptor’s active site. In addition, the stability of the docked poses of these compounds seemed to be stable after ∼45 ns computer simulations.

Conclusion

The present study suggests that kaempferol 3-rutinoside-4′-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 could strongly bind to the MAPK3 catalytic site and could be assigned as a potent inhibitor for MAPK3. These findings may be helpful in the treatment of various cancers. However, further validation experiments are needed.

Autor:innen und Institutionen

  • Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Oral and Maxillofacial Medicine, Faculty of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran.

ORCID-Profile: Amir Taherkhani, Parita Khodadadi, Lida Samie, Zahra Azadian, Zeynab Bayat

Förderung

  • Hamadan University of Medical Sciences

Zitieren

APA

Taherkhani, A., Khodadadi, P., Samie, L., Azadian, Z., & Bayat, Z. (2023). Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach. International Journal of Analytical Chemistry, 2023, 1-16. https://doi.org/10.1155/2023/8899240

Vancouver

Taherkhani A, Khodadadi P, Samie L, Azadian Z, Bayat Z. Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach. International Journal of Analytical Chemistry. 2023;2023:1-16. doi:10.1155/2023/8899240

BibTeX
@article{Taherkhani2023,
  author = {Taherkhani, Amir and Khodadadi, Parita and Samie, Lida and Azadian, Zahra and Bayat, Zeynab},
  title = {Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach},
  journal = {International Journal of Analytical Chemistry},
  year = {2023},
  volume = {2023},
  pages = {1--16},
  doi = {10.1155/2023/8899240}
}
Kostenlos starten →